Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
Teladoc Health (NYSE:TDOC), a leader in virtual care, has announced an inducement award for a new employee.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teladoc Health (NYSE:TDOC), a leader in virtual care, has announced an inducement award for a new employee. Terre Layton, joining as Senior Vice President of Product for BetterHelp, received 50,000 restricted stock units of Teladoc Health's common stock on September 1, 2024. The vesting schedule is structured as follows:
- One-third of the shares vest on the first anniversary of the grant date
- The remaining two-thirds vest quarterly over the subsequent two years
This award, approved by the Compensation Committee of Teladoc's Board of Directors, was granted under the company's 2023 Employment Inducement Incentive Award Plan, in compliance with NYSE Rule 303A.08.
Positive
- Attraction of high-level talent with Terre Layton joining as SVP of Product for BetterHelp
- Alignment of employee interests with shareholders through stock-based compensation
Negative
- Potential dilution of existing shareholders due to issuance of new stock units
Details
News Market Reaction – TDOC
The recorded move for TDOC in the trading session of this news was -4.26%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PURCHASE, NY, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued an inducement award to a new employee.
Effective September 1, 2024, in connection with commencing employment as Senior Vice President of Product, BetterHelp, Terre Layton was granted an award of restricted stock units covering 50,000 shares of Teladoc Health’s common stock, par value
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com
Media:
Chris Stenrud
617-444-9612
pr@teladochealth.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.